DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Kavanaugh A, Kremer J, Ponce L. et al.
Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2).
Ann Rheum Dis 2017;
76: 1009-1019
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.